84 related articles for article (PubMed ID: 26479703)
1. Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro.
Li L; Xu N; Fan N; Meng Q; Luo W; Lv L; Ma W; Liu X; Liu L; Xu F; Wang H; Mao W; Li Y
Oncol Rep; 2015 Nov; 34(5):2325-32. PubMed ID: 26479703
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract][Full Text] [Related]
4. Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Zhang Y; Song H; Miao Y; Wang R; Chen L
Cancer Sci; 2010 Apr; 101(4):934-40. PubMed ID: 20180809
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Grin A; Samaan S; Tripathi M; Rotondo F; Kovacs K; Bassily MN; Yousef GM
Hum Pathol; 2015 Apr; 46(4):541-8. PubMed ID: 25649006
[TBL] [Abstract][Full Text] [Related]
6. [Enhancement of kallikrein-related peptidase 10 expression attenuates proliferation and invasiveness of human tongue cancer cells in vitro].
Zheng H; Zhang W; Wang X; Zhao G
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1796-9. PubMed ID: 23268413
[TBL] [Abstract][Full Text] [Related]
7. NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Hu J; Lei H; Fei X; Liang S; Xu H; Qin D; Wang Y; Wu Y; Li B
Sci Rep; 2015 Nov; 5():17426. PubMed ID: 26616394
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of cisplatin sensitivity of human esophageal squamous cancer cell lines using in-air micro-PIXE.
Tanaka N; Kimura H; Faried A; Sakai M; Sano A; Inose T; Sohda M; Okada K; Nakajima M; Miyazaki T; Fukuchi M; Kato H; Asao T; Kuwano H; Satoh T; Oikawa M; Kamiya T; Arakawa K
Cancer Sci; 2010 Jun; 101(6):1487-92. PubMed ID: 20331629
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
10. TNFAIP8 regulates cisplatin resistance through TAF-Iα and promotes malignant progression of esophageal cancer.
Zhang DL; Yang N
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4775-4784. PubMed ID: 32432789
[TBL] [Abstract][Full Text] [Related]
11. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase-C2β inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma.
Liu Z; Sun C; Zhang Y; Ji Z; Yang G
J Int Med Res; 2011; 39(4):1319-32. PubMed ID: 21986133
[TBL] [Abstract][Full Text] [Related]
13. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma.
Kondo K; Yamasaki S; Sugie T; Teratani N; Kan T; Imamura M; Shimada Y
Int J Cancer; 2006 Jan; 118(1):230-42. PubMed ID: 16003725
[TBL] [Abstract][Full Text] [Related]
15. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
16. β-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression.
Hu Z; Wu H; Li Y; Hou Q; Wang Y; Li S; Xia B; Wu S
Anticancer Drugs; 2015 Jun; 26(5):531-9. PubMed ID: 25646744
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells.
Tyagi S; Bhui K; Singh R; Singh M; Raisuddin S; Shukla Y
Biochem Pharmacol; 2010 Nov; 80(9):1326-34. PubMed ID: 20655883
[TBL] [Abstract][Full Text] [Related]
18. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-related peptidase 10 predicts prognosis and mediates tumor immunomodulation in colorectal cancer.
Luo YC; Lv YL; He RX; Shi XX; Jiang T
Biochem Biophys Res Commun; 2023 Dec; 689():149217. PubMed ID: 37972446
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study.
Chen Y; Li LB; Zhang J; Tang DP; Wei JJ; Zhuang ZH
Lipids Health Dis; 2018 Dec; 17(1):290. PubMed ID: 30579354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
